Search research articles
Contact Us
Filters
Showing results (21-30 of 213) with videos related to
Page
of 22
Sort By:
The Prostate
|
June 8, 2021
Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data
Christoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Urologic Oncology
|
June 7, 2021
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center
Christoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
December 4, 2020
Influence of an Early Application of Mammalian Target of Rapamycin Inhibitors Everolimus and Sirolimus on Acute Vascular Inflammatory Responses After Ischemia-Reperfusion Injury
Mike Wenzel, Henryk Haffer, Pengfei Wang, et al.
Urologia Internationalis
|
February 7, 2024
Why Do Men Reject Adjuvant Radiotherapy following Radical Prostatectomy? A Systematic Survey
Silvan Sigg, Winfried Arnold, Nico Christian Grossmann, et al.
European Urology
|
June 24, 2021
Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort
Christoph Würnschimmel, Randi Marisa Pose, Mike Wenzel, et al.
Prostate International
|
October 25, 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
Felix Preisser, Felix K-H Chun, Severine Banek, et al.
Urologie (Heidelberg, Germany)
|
December 21, 2023
[First clinical and oncological experiences with triplet therapy for high-volume metastatic hormone-sensitive prostate cancer]
Mike Wenzel, Benedikt Hoeh, Jan Kasparek, et al.
Urologie (Heidelberg, Germany)
|
May 19, 2026
[Artificial intelligence in daily urological care: results of the AI barometer]
Nicolas Carl, Frederik Wessels, Jonathan Jeutner, et al.
European Urology Open Science
|
June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer
Mike Wenzel, Thomas Steuber, Carolin Siech, et al.
European Urology Focus
|
September 4, 2022
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis
Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al.
Page
of 22
Search research articles
Search
Showing results (21-30 of 213) with videos related to
Sort By:
Page
of 22
The Prostate
|
June 8, 2021
Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data
Christoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Urologic Oncology
|
June 7, 2021
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center
Christoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
December 4, 2020
Influence of an Early Application of Mammalian Target of Rapamycin Inhibitors Everolimus and Sirolimus on Acute Vascular Inflammatory Responses After Ischemia-Reperfusion Injury
Mike Wenzel, Henryk Haffer, Pengfei Wang, et al.
Urologia Internationalis
|
February 7, 2024
Why Do Men Reject Adjuvant Radiotherapy following Radical Prostatectomy? A Systematic Survey
Silvan Sigg, Winfried Arnold, Nico Christian Grossmann, et al.
European Urology
|
June 24, 2021
Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort
Christoph Würnschimmel, Randi Marisa Pose, Mike Wenzel, et al.
Prostate International
|
October 25, 2021
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
Felix Preisser, Felix K-H Chun, Severine Banek, et al.
Urologie (Heidelberg, Germany)
|
December 21, 2023
[First clinical and oncological experiences with triplet therapy for high-volume metastatic hormone-sensitive prostate cancer]
Mike Wenzel, Benedikt Hoeh, Jan Kasparek, et al.
Urologie (Heidelberg, Germany)
|
May 19, 2026
[Artificial intelligence in daily urological care: results of the AI barometer]
Nicolas Carl, Frederik Wessels, Jonathan Jeutner, et al.
European Urology Open Science
|
June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer
Mike Wenzel, Thomas Steuber, Carolin Siech, et al.
European Urology Focus
|
September 4, 2022
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis
Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al.
Page
of 22